Mirati Therapeutics
Stock Forecast, Prediction & Price Target
Mirati Therapeutics Financial Estimates
Mirati Therapeutics Revenue Estimates
Mirati Therapeutics EBITDA Estimates
Mirati Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $13.39M N/A | $72.09M 438.08% | $12.43M -82.74% | Avg: $316.48M Low: $206.04M High: $513.05M avg. 2444.87% | |||
Net Income
% change YoY
| $-357.42M N/A | $-581.78M -62.77% | $-740.86M -27.34% | Avg: $-585.46M Low: $-773.19M High: $-240.67M avg. 20.97% | |||
EBITDA
% change YoY
| $-368.72M N/A | $-573.18M -55.45% | $-759.58M -32.52% | Avg: $-316.48M Low: $-206.04M High: $-513.05M avg. 58.33% | |||
EPS
% change YoY
| -$7.94 N/A | -$11.21 -41.18% | -$13.18 -17.57% | Avg: -$8.37 Low: -$13.75 High: -$4.28 avg. 36.49% | |||
Operating Expenses
% change YoY
| $382.76M N/A | $645.27M 68.58% | $771.42M 19.55% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Mirati Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.97% in 2025-2025.
We have gathered data from 11 analysts. Their low estimate is -773.19M, average is -585.46M and high is -240.67M.
What is Mirati Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2444.87% in 2025-2025.
We have gathered data from 13 analysts. Their low revenue estimate is $206.04M, average is $316.48M and high is $513.05M.
What is Mirati Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 36.49% in 2025-2025.
We have gathered data from 11 analysts. Their low earnings per share estimate is -$13.75, average is -$8.37 and high is $-4.28.
What is the best performing analyst?
In the last twelve months analysts have been covering Mirati Therapeutics stock. The most successful analyst is Swapnil Malekar.